Skip to main content
Martin Sanda, MD, Urology, Atlanta, GA

MartinGSandaMD

Urology Atlanta, GA

Surgical Oncology

Professor and Chairman of Urology, Emory University School of Medicine

Dr. Sanda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sanda's full profile

Already have an account?

  • Office

    PO Box
    Bldg B
    Atlanta, GA 30322
    Phone+1 404-778-6874

Summary

  • Dr. Martin Sanda is Professor and Chair of Urology at Emory Healthcare in Atlanta, GA and is affiliated with multiple hospitals in the area, including Emory University Hospital, Emory Saint Joseph's Hospital of Atlanta, and others. He received his medical degree from Columbia University College of Physicians & Surgeons, completed his Urology residency at Johns Hopkins, and has been in practice 25 years. He specializes in urological oncology with focus on prostate cancer, and has managed the care and treatment of over 2500 men with newly diagnosed prostate cancer.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Urology, 1991 - 1995
  • National Cancer Institute
    National Cancer InstituteFellowship, Tumor Immunology, 1989 - 1991
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Surgery, 1987 - 1989
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1987

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2013 - 2026
  • MA State Medical License
    MA State Medical License 2003 - 2014
  • MI State Medical License
    MI State Medical License 1995 - 2005
  • MD State Medical License
    MD State Medical License 1989 - 1995
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Boston Magazine Castle Connolly, 2008-2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Impact of Prebiopsy Magnetic Resonance Imaging of the Prostate on Cancer Detection and Treatment Patterns  
    Martin G Sanda, Christopher P Filson, Urologic Oncology

Lectures

  • Georgia Urological Association 2013 Annual Spring Meeting 
    Georgia Urological Association, Greensboro, Georgia - 3/1/2013

Press Mentions

  • Immune Cell Find Boosts Cancer Immunotherapy Hopes
    Immune Cell Find Boosts Cancer Immunotherapy HopesOctober 26th, 2024
  • Immune Cell Discovery Offers New Potential for Cancer Immunotherapy
    Immune Cell Discovery Offers New Potential for Cancer ImmunotherapyOctober 25th, 2024
  • Research Roundup: Recent Grants and Publications for Emory Faculty and Staff
    Research Roundup: Recent Grants and Publications for Emory Faculty and StaffNovember 9th, 2021
  • Join now to see all

Grant Support

  • Harvard/Michigan/Cornell Prostate Cancer Biomarker Clinical Validation CenterNational Cancer Institute2010–2011
  • Effectiveness Of Robotic Compared To Standard Prostatectomy For Prostate CancerNational Institute Of Biomedical Imaging And Bioengineering2009–2010
  • Effectiveness Of Early Stage Prostate Cancer TreatmentNational Cancer Institute2009–2010
  • Harvard/Michigan Prostate Cancer Biomarker Clinical CtrNational Cancer Institute2005–2010
  • University Of Michigan O'Brien Center For Urology ResearchNational Institute Of Diabetes And Digestive And Kidney Diseases2007
  • Survivor Qol/Spouse Satisfaction After Prostate TherapyNational Cancer Institute2004–2007
  • Modulating Tolerance For Prostate Cancer Antigen VaccineNational Cancer Institute2003
  • Survivor Qol/Spouse Satisfaction After Prostate TherapyNational Cancer Institute2002–2003
  • Modulating Tolerance For Prostate Cancer Antigen VaccineNational Cancer Institute2000–2003
  • Recombinant Vaccinia/Psa Vaccine In Patients With Recurrence Of Prostate CancerNational Center For Research Resources1998–2002
  • Vaccinia PSA For Androgen-Modulated Post-Surgical Recurrence Of Prostate CancerNational Cancer Institute1998–2002
  • Targeting PCD In Bladder CancerNational Cancer Institute1998–2002
  • Prostate Cancer Gene Therapy With Recombinant VaccinesNational Cancer Institute1996–1999